Asensus Surgical, Inc. (NYSE American: ASXC), a medical device
company that is digitizing the interface between the surgeon and
the patient to pioneer a new era of Performance-Guided Surgery™,
today announced that the Dr. von Hauner Children’s Hospital at the
Ludwig Maximilians University Munich (“LMU”), located in Munich,
Germany, has entered into an agreement to lease and utilize a
Senhance® Surgical System.
“We are very excited that the LMU University Hospital will be
utilizing a Senhance System as part of their pediatric surgery
department. This is a significant milestone for Asensus as this
represents the first Senhance program devoted entirely to pediatric
procedures,” said Anthony Fernando, Asensus Surgical President and
CEO. “Senhance has been developed to help surgeons deliver better
patient outcomes by utilizing advanced minimally invasive
instrumentation such as 3mm instruments, combined with haptic
feedback for added fidelity for the surgeon. We look forward to
partnering with the pediatric team at LMU University Hospital to
transform the way they deliver care to their pediatric
patients.”
Senhance Surgical System powered by the
Intelligent Surgical Unit™ (ISU™) is designed to increase surgeon
control and reduce surgical variability through the addition of
machine vision, augmented intelligence, and deep learning
capabilities throughout the surgical experience.
Pediatric surgeons are skilled at minimally invasive approaches
to treat a wide range of patients, from infants to adolescents.
Working with small, delicate anatomy presents unique obstacles for
the surgeons, including challenges with visualization, instrument
control, and surgical access. Senhance’s digital fulcrum and tremor
filtration can minimize traumatic forces exerted by instruments on
the abdominal wall. The combination of these two features creates
an optimal micro laparoscopic working environment for the surgeon.
Furthermore, the Senhance system is the only robotic assisted
surgical system in the world to provide fully reusable 3-millimeter
instruments as well as haptic feedback. These advanced
capabilities, only available with the Senhance Surgical System,
have the potential to reduce invasiveness, especially in complex
pediatric surgery, thereby meaningfully improving outcomes for
those patients.
“As a pediatric surgeon for over 16 years, I am driven to find
the most effective and least invasive way to help smaller patients.
We are constantly looking to leverage the digital transformation of
patient care to deliver the best possible outcomes to the children
that come to our facilities,” said Prof. Dr. Oliver Muensterer,
Chairman and Professor, Pediatric Surgery, Dr. von Hauner
Children’s Hospital of the LMU Munich. “Until now, there has not
been an advanced robotic option for pediatric procedures, instead
we have been forced to rely on more traditional, more invasive,
procedural solutions. The platform will be a great asset to our
hospital, and we are very excited to launch our Senhance pediatric
surgical program.”
Germany continues to be a focus market for the Company due its
size, as it is the largest surgical market in Europe, and its
hospitals’ interests to focus on adopting novel technologies in the
operating room. With nine installations in the country, the Company
has seen the positive benefits of its commercial and clinical
strategies, and expects to see continued growth in the country
moving forward.
About Clinical University of Munich
The LMU University Hospital Munich is one of the largest
university hospitals in Germany and Europe has two locations in
Munich: Campus Großhadern and Campus Downtown. With around 500,000
patients per year, the LMU Medical Center is trusted for the
competence, care and commitment of their employees in 28 specialist
clinics, thirteen institutes and seven departments as well as 53
interdisciplinary centers.
The Dr. von Hauner Children’s Hospital of the LMU Munich is one
of the biggest departments for pediatric surgery in Germany, and
since 1846 has treated children according to their motto: Helfen
Forschen Heilen - Help Research Heal. The spectrum of the clinic
includes the treatment of congenital malformations, the treatment
of the consequences of accidents and burns in children, pediatric
tumor surgery, pediatric urology, pediatric neurosurgery, general
abdominal and thoracic surgery in children, colorectal pediatric
surgery, and specifically the treatment of funnel chest, keel
chest, palmar hyperhydrosis and other diseases specifically related
to pediatric surgery.
In addition to clinical activities, the Dr. von Hauner
Children’s Hospital of the LMU Munich is also one of the leading
academic pediatric surgeries in the German-speaking region in the
research and development of innovative therapy methods.
About Asensus Surgical, Inc.
Asensus Surgical, Inc. is digitizing the interface between the
surgeon and patient to pioneer a new era of Performance-Guided
Surgery by unlocking clinical intelligence for surgeons to enable
consistently superior outcomes and a new standard of surgery. This
builds upon the foundation of Digital Laparoscopy with the Senhance
Surgical System powered by the Intelligent Surgical Unit™ (ISU™) to
increase surgeon control and reduce surgical variability. With the
addition of machine vision, augmented intelligence, and deep
learning capabilities throughout the surgical experience, we intend
to holistically address the current clinical, cognitive and
economic shortcomings that drive surgical outcomes and value-based
healthcare. Learn more about Performance-Guided Surgery and Digital
Laparoscopy with the Senhance Surgical System here:
www.senhance.com. Now available for sale in the
US, EU, Japan, Russia, and select other countries. For a complete
list of indications for use, visit:
www.senhance.com/indications. For more
information, visit www.asensus.com.
Follow Asensus
Email Alerts: https://ir.asensus.com/email-alerts
LinkedIn:
https://www.linkedin.com/company/asensus-surgical-inc
Twitter: https://twitter.com/AsensusSurgical
YouTube: https://www.youtube.com/c/transenterix
Vimeo: https://vimeo.com/asxc
TikTok: https://www.tiktok.com/@asensus_surgical
Forward-Looking Statements
This press release includes statements relating to the Senhance
Surgical System and the Dr. von Hauner Children's Hospital at the
Ludwig Maximilians University Munich initiating a program dedicated
to pediatric procedures with the Senhance System. These statements
and other statements regarding our future plans and goals
constitute "forward looking statements" within the meaning of
Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of 1934, and are intended to qualify for
the safe harbor from liability established by the Private
Securities Litigation Reform Act of 1995. Such statements are
subject to risks and uncertainties that are often difficult to
predict, are beyond our control and which may cause results to
differ materially from expectations and include whether the
Senhance Surgical System will be a great addition to Dr. von Hauner
Children's Hospital at the Ludwig Maximilians University Munich and
its minimally invasive portfolio; whether the advanced capabilities
of the Senhance Surgical System will reduce invasiveness,
especially in complex pediatric surgery, thereby meaningfully
improving outcomes for those patients. For a discussion of the
risks and uncertainties associated with the Company’s business,
please review our filings with the Securities and Exchange
Commission (SEC), including our Annual Report on Form 10-K for the
year ended December 31, 2021, filed with the SEC on February 28,
2022 and our other filings we make with the SEC. You are cautioned
not to place undue reliance on these forward looking statements,
which are based on our expectations as of the date of this press
release and speak only as of the origination date of this press
release. We undertake no obligation to publicly update or revise
any forward-looking statement, whether as a result of new
information, future events or otherwise.
INVESTOR CONTACT:
Mark Klausner or Mike Vallie, 443-213-0499
invest@asensus.com
MEDIA CONTACT:
Lauren Stredler, 847-271-6891
CG Life
lstredler@cglife.com
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/39efb789-f3ad-44c7-ac0c-3f08abe0ca92
Asensus Surgical (AMEX:ASXC)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
Asensus Surgical (AMEX:ASXC)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024